Neuroinflammation in animal models of traumatic brain injury

Journal of Neuroscience Methods

Volumn 272, Issue , 2016, Pages 38-49

  Chiu, Chong Chi ^a   Liao, Yi En ^b   Yang, Ling Yu ^c   Wang, Jing Ya ^c   Tweedie, David ^d   Karnati, Hanuma K ^d   Greig, Nigel H ^d   Wang, Jia Yi ^c,e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Astrocytes; Controlled cortical impact; Glia cells; Lateralfluid percussion; Measurements evaluating neuroinflammation; Microglia; Neuroinflammation; Traumatic brain injury (TBI); Weight drop impact

Indexed keywords

AQUAPORIN 4; CD11B ANTIGEN; CD68 ANTIGEN; CHEMOKINE; CYCLOOXYGENASE 2; CYTOKINE; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STROMELYSIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL MODEL; ASTROCYTE; BRAIN CONCUSSION; CELL ACTIVATION; CELL DEATH; DISEASE COURSE; GLIOSIS; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; METABOLISM;

ANIMALS; BRAIN; BRAIN INJURIES, TRAUMATIC; DISEASE MODELS, ANIMAL; INFLAMMATION;

EID: 84994013718     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2016.06.018     Document Type: Review

References (145)

1. Acosta, S.A., Tajiri, N., Shinozuka, K., Ishikawa, H., Grimmig, B., Diamond, D.M., Sanberg, P.R., Bickford, P.C., Kaneko, Y., Borlongan, C.V., Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLoS One, 8, 2013, e53376.
2. Aihara, N., Hall, J.J., Pitts, L.H., Fukuda, K., Noble, L.J., Altered immunoexpression of microglia and macrophages after mild head injury. J. Neurotrauma 12 (1995), 53–63.
3. Bains, M., Hall, E.D., Antioxidant therapies in traumatic brain and spinal cord injury. Biochim. Biophys. Acta 1822 (2012), 675–684.
4. Bal-Price, A., Brown, G.C., Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21 (2001), 6480–6491.
5. Bar-Or, D., Bar-Or, R., Rael, L.T., Brody, E.N., Oxidative stress in severe acute illness. Redox Biol. 4 (2015), 340–345.
6. Baratz, R., Tweedie, D., Wang, J.Y., Rubovitch, V., Luo, W., Hoffer, B.J., Greig, N.H., Pick, C.G., Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice. J. Neuroinflammation, 12, 2015, 45.
7. Bardehle, S., Kruger, M., Buggenthin, F., Schwausch, J., Ninkovic, J., Clevers, H., Snippert, H.J., Theis, F.J., Meyer-Luehmann, M., Bechmann, I., Dimou, L., Gotz, M., Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat. Neurosci. 16 (2013), 580–586.
8. Barnes, D.E., Kaup, A., Kirby, K.A., Byers, A.L., Diaz-Arrastia, R., et al. Traumatic brain injury and risk of dementia in older veterans. Neurology 83:4 (2014), 312–319.
9. Bauernfeind, F., Bartok, E., Rieger, A., Franchi, L., Nunez, G., Hornung, V., Cutting edge: reactive oxygen species inhibitors block priming, but not activation of the NLRP3 inflammasome. J. Immunol. 187 (2011), 613–617.
10. Buffo, A., Rolando, C., Ceruti, S., Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem. Pharmacol. 79 (2010), 77–89.
11. Chen, G., Shi, J., Jin, W., Wang, L., Xie, W., Sun, J., Hang, C., Progesterone administration modulates TLRs/NF-kappaB signaling pathway in rat brain after cortical contusion. Ann. Clin. Lab. Sci. 38 (2008), 65–74.
12. Chen, C.C., Hung, T.H., Wang, Y.H., Lin, C.W., Wang, P.Y., Lee, C.Y., Chen, S.F., Wogonin improves histological and functional outcomes, and reduces activation of TLR4/NF-kappaB signaling after experimental traumatic brain injury. PLoS One, 7, 2012, e30294.
13. Chen, Y., Garcia, G.E., Huang, W., Constantini, S., The involvement of secondary neuronal damage in the development of neuropsychiatric disorders following brain insults. Front. Neurol., 5, 2014, 22.
14. Cheng, G., Kong, R.H., Zhang, L.M., Zhang, J.N., Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies. Br. J. Pharmacol. 167 (2012), 699–719.
15. Clark, R.S., Schiding, J.K., Kaczorowski, S.L., Marion, D.W., Kochanek, P.M., Neutrophil accumulation after traumatic brain injury in rats: comparison of weight drop and controlled cortical impact models. J. Neurotrauma 11 (1994), 499–506.
16. Dalgard, C.L., Cole, J.T., Kean, W.S., Lucky, J.J., Sukumar, G., McMullen, D.C., Pollard, H.B., Watson, W.D., The cytokine temporal profile in rat cortex after controlled cortical impact. Front. Mol. Neurosci., 5, 2012, 6.
17. Das, M., Leonardo, C.C., Rangooni, S., Pennypacker, K.R., Mohapatra, S., Mohapatra, S.S., Lateral fluid percussion injury of the brain induces CCL20 inflammatory chemokine expression in rats. J. Neuroinflammation, 8, 2011, 148.
18. Das, M., Mohapatra, S., Mohapatra, S.S., New perspectives on central and peripheral immune responses to acute traumatic brain injury. J. Neuroinflammation, 9, 2012, 236.
19. Deselms, H., Maggio, N., Rubovitch, V., Chapman, J., Schreiber, S., Tweedie, D., Kim, D.S., Greig, N.H., Pick, C.G., Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development. J. Neurosci. Methods, 2016 (Epub ahead of print).
20. Di Battista, A.P., Buonora, J.E., Rhind, S.G., Hutchison, M.G., Baker, A.J., Rizoli, S.B., Diaz-Arrastia, R., Mueller, G.P., Blood biomarkers in moderate-to-severe traumatic brain injury: potential utility of a multi-marker approach in characterizing outcome. Front. Neurol., 6, 2015, 110.
21. Di Battista, A.P., Rhind, S.G., Hutchison, M.G., Hassan, S., Shiu, M.Y., Inaba, K., Topolovec-Vranic, J., Neto, A.C., Rizoli, S.B., Baker, A.J., Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. J. Neuroinflammation, 13, 2016, 40.
22. Ding, K., Wang, H., Xu, J., Li, T., Zhang, L., Ding, Y., Zhu, L., He, J., Zhou, M., Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism. Free Radical Biol. Med. 73 (2014), 1–11.
23. Ding, K., Wang, H., Xu, J., Lu, X., Zhang, L., Zhu, L., Melatonin reduced microglial activation and alleviated neuroinflammation induced neuron degeneration in experimental traumatic brain injury: possible involvement of mTOR pathway. Neurochem. Int. 76 (2014), 23–31.
24. Dong, X.Q., Yu, W.H., Hu, Y.Y., Zhang, Z.Y., Huang, M., Oxymatrine reduces neuronal cell apoptosis by inhibiting Toll-like receptor 4/nuclear factor kappa-B-dependent inflammatory responses in traumatic rat brain injury. Inflamm. Res. 60 (2011), 533–539.
25. Dougherty, K.D., Dreyfus, C.F., Black, I.B., Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury. Neurobiol. Dis. 7 (2000), 574–585.
26. Du, Y., Dreyfus, C.F., Oligodendrocytes as providers of growth factors. J. Neurosci. Res. 68 (2002), 647–654.
27. Faden, A.I., Loane, D.J., Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?. Neurotherapeutics 12:1 (2015), 143–150.
28. Fan, L., Young, P.R., Barone, F.C., Feuerstein, G.Z., Smith, D.H., McIntosh, T.K., Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. Brain Res. Mol. Brain Res. 36 (1996), 287–291.
29. Farina, C., Aloisi, F., Meinl, E., Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28 (2007), 138–145.
30. Fenn, A.M., Henry, C.J., Huang, Y., Dugan, A., Godbout, J.P., Lipopolysaccharide-induced IL-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice. Brain Behav. Immun. 26 (2012), 766–777.
31. Fenn, A.M., Gensel, J.C., Huang, Y., Popovich, P.G., Lifshitz, J., Godbout, J.P., Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia. Biol. Psychiatry 76 (2014), 575–584.
32. Ferreira, A.P., Rodrigues, F.S., Della-Pace, I.D., Mota, B.C., Oliveira, S.M., Velho Gewehr Cde, C., Bobinski, F., de Oliveira, C.V., Brum, J.S., Oliveira, M.S., Furian, A.F., de Barros, C.S., Ferreira, J., Santos, A.R., Fighera, M.R., Royes, L.F., The effect of NADPH-oxidase inhibitor apocynin on cognitive impairment induced by moderate lateral fluid percussion injury: role of inflammatory and oxidative brain damage. Neurochem. Int. 63 (2013), 583–593.
33. Fitch, M.T., Silver, J., CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp. Neurol. 209 (2008), 294–301.
34. Frankola, K.A., Greig, N.H., Luo, W., Tweedie, D., Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol. Disord. Drug Targets 10:3 (2011), 391–403.
35. Galgano, M., Russell, T., Mc Gillis, S., Toshkezi, G., Chin, L., Zhao, L.R., A review of traumatic brain injury animal models: are we lacking adequate models replicating chronic traumatic encephalopathy?. J. Neurol. Neurobiol., 2(1), 2015, 10.16966/2379-7150.117.
36. Gandy, S., Ikonomovic, M.D., Mitsis, E., Elder, G., Ahlers, S.T., Barth, J., Stone, J.R., DeKosky, S.T., Chronic traumatic encephalopathy: clinical-biomarker correlations and current concepts in pathogenesis. Mol. Neurodegener., 9, 2014, 37.
37. Gardner, R.C., Yaffe, K., Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol. Cell Neurosci. 66:Pt B (2015), 75–80.
38. Gardner, R.C., Burke, J.F., Nettiksimmons, J., Kaup, A., Barnes, D.E., Yaffe, K., Dementia risk after traumatic brain injury vs nonbrain trauma: the role of age and severity. JAMA Neurol. 71:12 (2014), 1490–1497.
39. Gardner, R.C., Burke, J.F., Nettiksimmons, J., Goldman, S., Tanner, C.M., Yaffe, K., Traumatic brain injury in later life increases risk for Parkinson disease. Ann. Neurol. 77:6 (2015), 987–995.
40. Gervasi, N.M., Kwok, J.C., Fawcett, J.W., Role of extracellular factors in axon regeneration in the CNS: implications for therapy. Regen. Med. 3 (2008), 907–923.
41. Glushakova, O.Y., Johnson, D., Hayes, R.L., Delayed increases in microvascular pathology after experimental traumatic brain injury are associated with prolonged inflammation, blood-brain barrier disruption, and progressive white matter damage. J. Neurotrauma 31 (2014), 1180–1193.
42. Goldstein, L.E., Fisher, A.M., Tagge, C.A., Zhang, X.L., Velisek, L., Sullivan, J.A., Upreti, C., Kracht, J.M., Ericsson, M., Wojnarowicz, M.W., Goletiani, C.J., Maglakelidze, G.M., Casey, N., Moncaster, J.A., Minaeva, O., Moir, R.D., Nowinski, C.J., Stern, R.A., Cantu, R.C., Geiling, J., Blusztajn, J.K., Wolozin, B.L., Ikezu, T., Stein, T.D., Budson, A.E., Kowall, N.W., Chargin, D., Sharon, A., Saman, S., Hall, G.F., Moss, W.C., Cleveland, R.O., Tanzi, R.E., Stanton, P.K., McKee, A.C., Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci. Transl. Med., 4(134), 2012 134ra60.
43. Greig, N.H., Tweedie, D., Rachmany, L., Li, Y., Rubovitch, V., Schreiber, S., Chiang, Y.H., Hoffer, B.J., Miller, J., Lahiri, D.K., Sambamurti, K., Becker, R.E., Pick, C.G., Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury. Alzheimers Dement. 10:Suppl. 1 (2014), S62–7.
44. Gunther, M., Al Nimer, F., Gahm, C., Piehl, F., Mathiesen, T., iNOS-mediated secondary inflammatory response differs between rat strains following experimental brain contusion. Acta Neurochir. (Wien) 154 (2012), 689–697.
45. Gurung, P., Lukens, J.R., Kanneganti, T.D., Mitochondria: diversity in the regulation of the NLRP3 inflammasome. Trends Mol. Med. 21:3 (2015), 193–201.
46. Haneklaus, M., O'Neill, L.A., NLRP3 at the interface of metabolism and inflammation. Immunol. Rev. 265:1 (2015), 53–62.
47. Harry, G., Microglia during development and aging. Pharmacol. Ther. 139 (2013), 313–326.
48. He, Y., Qu, S., Wang, J., He, X., Lin, W., Zhen, H., Zhang, X., Neuroprotective effects of osthole pretreatment against traumatic brain injury in rats. Brain Res. 1433 (2012), 127–136.
49. Hiebert, J.B., Shen, Q., Thimmesch, A.R., Pierce, J.D., Traumatic brain injury and mitochondrial dysfunction. Am. J. Med. Sci. 350:2 (2015), 132–138.
50. Hyder, A.A., Wunderlich, C.A., Puvanachandra, P., Gururaj, G., Kobusingye, O.C., The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation 22:5 (2007), 341–353.
51. Israelsson, C., Bengtsson, H., Kylberg, A., Kullander, K., Lewén, A., Hillered, L., Ebendal, T., Distinct cellular patterns of upregulated chemokine expression supporting a prominent inflammatory role in traumatic brain injury. J. Neurotrauma 25:8 (2008), 959–974.
52. Israelsson, C., Wang, Y., Kylberg, A., Pick, C.G., Hoffer, B.J., Ebendal, T., Closed head injury in a mouse model results in molecular changes indicating inflammatory responses. J. Neurotrauma 26:8 (2009), 1307–1314.
53. Jafarian-Tehrani, M., Louin, G., Royo, N.C., Besson, V.C., Bohme, G.A., Plotkine, M., Marchand-Verrecchia, C., 1400 W, a potent selective inducible NOS inhibitor, improves histopathological outcome following traumatic brain injury in rats. Nitric Oxide 12 (2005), 61–69.
54. Jin, W., Wang, H., Ji, Y., Hu, Q., Yan, W., Chen, G., Yin, H., Increased intestinal inflammatory response and gut barrier dysfunction in Nrf2-deficient mice after traumatic brain injury. Cytokine 44 (2008), 135–140.
55. Jin, W., Wang, H., Yan, W., Xu, L., Wang, X., Zhao, X., Yang, X., Chen, G., Ji, Y., Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Inflamm., 2008, 2008, 725174.
56. Jin, W., Ni, H., Dai, Y., Wang, H., Lu, T., Wu, J., Jiang, J., Liang, W., Effects of tert-butylhydroquinone on intestinal inflammatory response and apoptosis following traumatic brain injury in mice. Mediators Inflamm., 2010, 2010, 502564.
57. John, G.R., Lee, S.C., Brosnan, C.F., Cytokines: powerful regulators of glial cell activation. Neuroscientist: Rev. J. Bringing Neurobiol. Neurol. Psychiatry 9 (2003), 10–22.
58. Jung, C.S., Wispel, C., Zweckberger, K., Beynon, C., Hertle, D., Sakowitz, O.W., Unterberg, A.W., Endogenous nitric-oxide synthase inhibitor ADMA after acute brain injury. Int. J. Mol. Sci. 15 (2014), 4088–4103.
59. Kabadi, S.V., Faden, A.I., Neuroprotective strategies for traumatic brain injury: improving clinical translation. Int. J. Mol. Sci. 15 (2014), 1216–1236.
60. Kamm, K., Vanderkolk, W., Lawrence, C., Jonker, M., Davis, A.T., The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat. J. Trauma 60 (2006), 152–157.
61. Kappe, C., Tracy, L.M., Patrone, C., Iverfeldt, K., Sjöholm, Å., GLP-1 secretion by microglial cells and decreased CNS expression in obesity. J. Neuroinflammation, 9, 2012, 276.
62. Karve, I.P., Taylor, J.M., Crack, P.J., The contribution of astrocytes and microglia to traumatic brain injury. Br. J. Pharmacol., 2015.
63. Knoblach, S.M., Fan, L., Faden, A.I., Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment. J. Neuroimmunology 95 (1999), 115–125.
64. Kobori, N., Clifton, G.L., Dash, P., Altered expression of novel genes in the cerebral cortex following experimental brain injury. Brain Res. Mol. Brain Res. 104 (2002), 148–158.
65. Kondo, A., Shahpasand, K., Mannix, R., Qiu, J., Moncaster, J., Chen, C.H., Yao, Y., Lin, Y.M., Driver, J.A., Sun, Y., Wei, S., Luo, M.L., Albayram, O., Huang, P., Rotenberg, A., Ryo, A., Goldstein, L.E., Pascual-Leone, A., McKee, A.C., Meehan, W., Zhou, X.Z., Lu, K.P., Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. Nature 523:7561 (2015), 431–436.
66. Kotter, M.R., Stadelmann, C., Hartung, H.P., Enhancing remyelination in disease – can we wrap it up?. Brain: J. Neurol. 134 (2011), 1882–1900.
67. Kou, Z., VandeVord, P.J., Traumatic white matter injury and glial activation: from basic science to clinics. Glia 62 (2014), 1831–1855.
68. Kumar, A., Loane, D.J., Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav. Immun. 26 (2012), 1191–1201.
69. Kumar, A., Alvarez-Croda, D.M., Stoica, B.A., Faden, A.I., Loane, D.J., Microglial/macrophage polarization dynamics following traumatic brain injury. J. Neurotrauma, 2016 (Epub ahead of print).
70. LaPlaca, M.C., Simon, C.M., Prado, G.R., Cullen, D.K., CNS injury biomechanics and experimental models. Prog. Brain Res. 161 (2007), 13–26.
71. Lagraoui, M., Latoche, J.R., Cartwright, N.G., Sukumar, G., Dalgard, C.L., Schaefer, B.C., Controlled cortical impact and craniotomy induce strikingly similar profiles of inflammatory gene expression, but with distinct kinetics. Front. Neurol., 3, 2012, 155.
72. Langlois, J.A., Rutland-Brown, W., Wald, M.M., The epidemiology and impact of traumatic brain injury: a brief overview. J. Head Trauma Rehabil. 21:5 (2006), 375–378.
73. Lee, H.F., Lee, T.S., Kou, Y.R., Anti-inflammatory and neuroprotective effects of triptolide on traumatic brain injury in rats. Respir. Physiol. Neurobiol. 182 (2012), 1–8.
74. Leonardo, C.C., Musso, J., Das, M., Rowe, D.D., Collier, L.A., Mohapatra, S., Pennypacker, K.R., CCL20 Is associated with neurodegeneration following experimental traumatic brain injury and promotes cellular toxicity in vitro. Transl. Stroke Res. 3 (2012), 357–363.
75. Liberto, C.M., Albrecht, P.J., Herx, L.M., Yong, V.W., Levison, S.W., Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89 (2004), 1092–1100.
76. Liu, S., Zhang, L., Wu, Q., Wang, T., Chemokine CCL2 induces apoptosis in cortex following traumatic brain injury. J. Mol. Neurosci.: MN 51 (2013), 1021–1029.
77. Lopez-Rodriguez, A.B., Acaz-Fonseca, E., Viveros, M.P., Garcia-Segura, L.M., Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit. PLoS One, 10, 2015, e0128782.
78. Lozano, D., Gonzales-Portillo, G.S., Acosta, S., de la Pena, I., Tajiri, N., Kaneko, Y., Borlongan, C.V., Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr. Dis. Treat. 11 (2015), 97–106.
79. Lu, K.T., Wang, Y.W., Wo, Y.Y., Yang, Y.L., Extracellular signal-regulated kinase-mediated IL-1-induced cortical neuron damage during traumatic brain injury. Neurosci. Lett. 386 (2005), 40–45.
80. Lu, K.T., Wang, Y.W., Yang, J.T., Yang, Y.L., Chen, H.I., Effect of interleukin-1 on traumatic brain injury-induced damage to hippocampal neurons. J. Neurotrauma 22 (2005), 885–895.
81. Lu, X.Y., Wang, H.D., Xu, J.G., Ding, K., Li, T., Deletion of Nrf2 exacerbates oxidative stress after traumatic brain injury in mice. Cell. Mol. Neurobiol. 35 (2015), 713–721.
82. Maas, A.I., Stocchetti, N., Bullock, R., Moderate and severe traumatic brain injury in adults. Lancet Neurol. 7 (2008), 728–741.
83. Marklund, N., Hillered, L., Animal modeling of traumatic brain injury in preclinical drug development: where do we go from here. Br. J. Pharmacol. 164 (2011), 1207–1229.
84. Mattiasson, G., Analysis of mitochondrial generation and release of reactive oxygen species. Cytometry A 62:2 (2004), 89–96.
85. Mayeux, J.P., Teng, S.X., Katz, P.S., Gilpin, N.W., Molina, P.E., Traumatic brain injury induces neuroinflammation and neuronal degeneration that is associated with escalated alcohol self-administration in rats. Behav. Brain Res. 279 (2015), 22–30.
86. McTigue, D.M., Tripathi, R.B., The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 107 (2008), 1–19.
87. Moppett, I.K., Traumatic brain injury: assessment, resuscitation and early management. Br. J. Anaesth. 99:1 (2007), 18–31.
88. Morganti-Kossmann, M.C., Rancan, M., Otto, V.I., Stahel, P.F., Kossmann, T., Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 16 (2001), 165–177.
89. Mouzon, B.C., Bachmeier, C., Ferro, A., Ojo, J.O., Crynen, G., Acker, C.M., Davies, P., Mullan, M., Stewart, W., Crawford, F., Chronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury model. Ann. Neurol. 75 (2014), 241–254.
90. Mrak, R.E., Griffin, W.S., Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 26 (2005), 349–354.
91. Mukherjee, S., Katki, K., Arisi, G.M., Foresti, M.L., Shapiro, L.A., Early TBI-induced cytokine alterations are similarly detected by two distinct methods of multiplex assay. Front. Mol. Neurosci., 4, 2011, 21.
92. Natale, J.E., Ahmed, F., Cernak, I., Stoica, B., Faden, A.I., Gene expression profile changes are commonly mod- ulated across models and species after traumatic brain injury. J. Neurotrauma 20 (2003), 907–927.
93. Nimmerjahn, A., Astrocytes going live: advances and challenges. J. Physiol. 587 (2009), 1639–1647.
94. Parekkadan, B., Berdichevsky, Y., Irimia, D., Leeder, A., Yarmush, G., Toner, M., Levine, J.B., Yarmush, M.L., Cell-cell interaction modulates neuroectodermal specification of embryonic stem cells. Neurosci. Lett. 438 (2008), 190–195.
95. Perez-Polo, J.R., Rea, H.C., Johnson, K.M., Parsley, M.A., Unabia, G.C., Xu, G., Infante, S.K., Dewitt, D.S., Hulsebosch, C.E., Inflammatory consequences in a rodent model of mild traumatic brain injury. J. Neurotrauma 30 (2013), 727–740.
96. Prins, M.L., Giza, C.C., Repeat traumatic brain injury in the developing brain. Int. J. Dev. Neurosci. 30 (2012), 185–190.
97. Probst, C., Mirzayan, M.J., Mommsen, P., Zeckey, C., Tegeder, T., Geerken, L., Maegele, M., Samii, A., van Griensven, M., Systemic inflammatory effects of traumatic brain injury, femur fracture, and shock: an experimental murine polytrauma model. Mediators Inflamm., 2012, 2012, 136020.
98. Rao, J.S., Kellom, M., Kim, H.W., Rapoport SI, reese EA: neuroinflammation and synaptic loss. Neurochem. Res. 37 (2012), 903–910.
99. Rau, T.F., Kothiwal, A., Rova, A., Rhoderick, J.F., Poulsen, D.J., Phenoxybenzamine is neuroprotective in a rat model of severe traumatic brain injury. Int. J. Mol. Sci. 15 (2014), 1402–1417.
100. Rhodes, J.K., Sharkey, J., Andrews, P.J., The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat. J. Neurotrauma 26 (2009), 507–525.
101. Riva-Depaty, I., Fardeau, C., Mariani, J., Bouchaud, C., Delhaye-Bouchaud, N., Contribution of peripheral macrophages and microglia to the cellular reaction after mechanical or neurotoxin-induced lesions of the rat brain. Exp. Neurol. 128 (1994), 77–87.
102. Ruff, R.L., Riechers, R.G., Effective treatment of traumatic brain injury: learning from experience. JAMA 308 (2012), 2032–2033.
103. Sajja, V.S., Perrine, S.A., Ghoddoussi, F., Hall, C.S., Galloway, M.P., VandeVord, P.J., Blast neurotrauma impairs working memory and disrupts prefrontal myo-inositol levels in rats. Mol. Cell. Neurosci. 59 (2014), 119–126.
104. Sandhir, R., Onyszchuk, G., Berman, N.E., Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury. Exp. Neurol. 213 (2008), 372–380.
105. Scherbel, U., Raghupathi, R., Nakamura, M., Saatman, K.E., Trojanowski, J.Q., Neugebauer, E., Marino, M.W., McIntosh, T.K., Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc. Natl. Acad. Sci. U.S.A. 96 (1999), 8721–8726.
106. Seker, E., Berdichevsky, Y., Begley, M.R., Reed, M.L., Staley, K.J., Yarmush, M.L., The fabrication of low-impedance nanoporous gold multiple-electrode arrays for neural electrophysiology studies. Nanotechnology, 21, 2010, 125504.
107. Semple, B.D., Bye, N., Rancan, M., Ziebell, J.M., Morganti-Kossmann, M.C., Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J. Cereb. Blood Flow Metab. 30 (2010), 769–782.
108. Semple, B.D., Kossmann, T., Morganti-Kossmann, M.C., Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J. Cereb. Blood Flow Metab. 30 (2010), 459–473.
109. Shi, H.Y., Hwang, S.L., Lee, K.T., Lin, C.L., Temporal trends and volume-outcome associations after traumatic brain injury: a 12-year study in Taiwan. J. Neurosurg. 118:4 (2013), 732–738.
110. Shohami, E., Bass, R., Wallach, D., Yamin, A., Gallily, R., Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 16 (1996), 378–384.
111. Shojo, H., Kaneko, Y., Mabuchi, T., Kibayashi, K., Adachi, N., Borlongan, C.V., Genetic and histologic evidence implicates role of inflammation in traumatic brain injury-induced apoptosis in the rat cerebral cortex following moderate fluid percussion injury. Neuroscience 171 (2010), 1273–1282.
112. Singh, K., Trivedi, R., Devi, M.M., Tripathi, R.P., Khushu, S., Longitudinal changes in the DTI measures, anti-GFAP expression and levels of serum inflammatory cytokines following mild traumatic brain injury. Exp. Neurol., 2015.
113. Stover, J.F., Schoning, B., Beyer, T.F., Woiciechowsky, C., Unterberg, A.W., Temporal profile of cerebrospinal fluid glutamate, interleukin-6, and tumor necrosis factor-alpha in relation to brain edema and contusion following controlled cortical impact injury in rats. Neurosci. Lett. 288 (2000), 25–28.
114. Streit, W.J., Mrak, R.E., Griffin, W.S., Microglia and neuroinflammation: a pathological perspective. J. Neuroinflammation, 1, 2004, 14.
115. Su, Y., Fan, W., Ma, Z., Wen, X., Wang, W., Wu, Q., Huang, H., Taurine improves functional and histological outcomes and reduces inflammation in traumatic brain injury. Neuroscience 266 (2014), 56–65.
116. Suh, H., Zhao, M.L., Derico, L., Choi, N., Lee, S.C., Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators. J. Neuroinflammation, 10, 2013, 37.
117. Tagliaferri, F., Compagnone, C., Korsic, M., Servadei, F., Kraus, J., A systematic review of brain injury epidemiology in Europe. Acta Neurochir. (Wien) 148:3 (2006), 255–268.
118. Tashlykov, V., Katz, Y., Volkov, A., Gazit, V., Schreiber, S., Zohar, O., Pick, C.G., Minimal traumatic brain injury induce apoptotic cell death in mice. J. Mol. Neurosci. 37:1 (2009), 16–24.
119. Teng, S.X., Molina, P.E., Acute alcohol intoxication prolongs neuroinflammation without exacerbating neurobehavioral dysfunction following mild traumatic brain injury. J. Neurotrauma 31 (2014), 378–386.
120. Tomura, S., Nawashiro, H., Otani, N., Uozumi, Y., Toyooka, T., Ohsumi, A., Shima, K., Effect of decompressive craniectomy on aquaporin-4 expression after lateral fluid percussion injury in rats. J. Neurotrauma 28 (2011), 237–243.
121. Trembovler, V., Beit-Yannai, E., Younis, F., Gallily, R., Horowitz, M., Shohami, E., Antioxidants attenuate acute toxicity of tumor necrosis factor-alpha induced by brain injury in rat. J. Interferon Cytokine Res. 19 (1999), 791–795.
122. Turner, J.N., Shain, W., Szarowski, D.H., Andersen, M., Martins, S., Isaacson, M., Craighead, H., Cerebral astrocyte response to micromachined silicon implants. Exp. Neurol. 156 (1999), 33–49.
123. Turner, R.C., Lucke-Wold, B.P., Robson, M.J., Omalu, B.I., Petraglia, A.L., Bailes, J.E., Repetitive traumatic brain injury and development of chronic traumatic encephalopathy: a potential role for biomarkers in diagnosis, prognosis, and treatment?. Front. Neurol., 3, 2013, 186.
124. Turtzo, L.C., Lescher, J., Janes, L., Dean, D.D., Budde, M.D., Frank, J.A., Macrophagic and microglial responses after focal traumatic brain injury in the female rat. J. Neuroinflammation, 11, 2014, 82.
125. Tweedie, D., Milman, A., Holloway, H.W., Li, Y., Harvey, B.K., Shen, H., Pistell, P.J., Lahiri, D.K., Hoffer, B.J., Wang, Y., Pick, C.G., Greig, N.H., Apoptotic and behavioral sequelae of mild brain trauma in mice. J. Neurosci. Res. 85:4 (2007), 805–815.
126. Tweedie, D., Rachmany, L., Rubovitch, V., Lehrmann, E., Zhang, Y., Becker, K.G., Perez, E., Miller, J., Hoffer, B.J., Greig, N.H., Pick, C.G., Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice. Exp. Neurol. 239 (2013), 170–182.
127. Tweedie, D., Rachmany, L., Rubovitch, V., Zhang, Y., Becker, K.G., Perez, E., Hoffer, B.J., Pick, C.G., Greig, N.H., Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury. Neurobiol. Dis. 54 (2013), 1–11.
128. Tweedie, D., Rachmany, L., Kim, D.S., Rubovitch, V., Lehrmann, E., Zhang, Y., Becker, K.G., Perez, E., Pick, C.G., Greig, N.H., Mild traumatic brain injury-induced hippocampal gene expressions: the identification of target cellular processes for drug development. J. Neurosci. Methods, 2016 (Epub ahead of print).
129. Tweedie, D., Rachmany, L., Rubovitch, V., Li, Y., Holloway, H.W., Lehrmann, E., Zhang, Y., Becker, K.G., Perez, E., Hoffer, B.J., Pick, C.G., Greig, N.H., Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4. Alzheimers Dement. 12:1 (2016), 34–48.
130. Vaughan, D., Peters, A., Neuroglial cells in the cerebral cortex of rats from young adulthood to old age: an electron microscope study. J. Neurocytol. 3 (1974), 405–429.
131. Wang, G.H., Jiang, Z.L., Li, Y.C., Li, X., Shi, H., Gao, Y.Q., Vosler, P.S., Chen, J., Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats. J. Neurotrauma 28 (2011), 2123–2134.
132. Wei, L., Zhang, Y., Yang, C., Wang, Q., Zhuang, Z., Sun, Z., Neuroprotective effects of ebselen in traumatic brain injury model: involvement of nitric oxide and p38 mitogen-activated protein kinase signalling pathway. Clin. Exp. Pharmacol. Physiol. 41 (2014), 134–138.
133. Wojtala, A., Bonora, M., Malinska, D., Pinton, P., Duszynski, J., Wieckowski, M.R., Methods to monitor ROS production by fluorescence microscopy and fluorometry. Methods Enzymol. 542 (2014), 243–262.
134. Woodcock, T., Morganti-Kossmann, M.C., The role of markers of inflammation in traumatic brain injury. Front. Neurol., 4, 2013, 18.
135. Xiong, Y., Mahmood, A., Chopp, M., Animal models of traumatic brain injury. Nat. Rev. Neurosci. 14:2 (2013), 128–142.
136. Yang, S.H., Gangidine, M., Pritts, T.A., Goodman, M.D., Lentsch, A.B., Interleukin 6 mediates neuroinflammation and motor coordination deficits after mild traumatic brain injury and brief hypoxia in mice. Shock 40 (2013), 471–475.
137. Yang, S.H., Gustafson, J., Gangidine, M., Stepien, D., Schuster, R., Pritts, T.A., Goodman, M.D., Remick, D.G., Lentsch, A.B., A murine model of mild traumatic brain injury exhibiting cognitive and motor deficits. J. Surg. Res. 184 (2013), 981–988.
138. Ye, S., Johnson, R., An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation 9 (2001), 183–192.
139. Ye, Y., Xu, H., Zhang, X., Li, Z., Jia, Y., He, X., Huang, J.H., Association between toll-like receptor 4 expression and neural stem cell proliferation in the hippocampus following traumatic brain injury in mice. Int. J. Mol. Sci. 15 (2014), 12651–12664.
140. Yokobori, S., Mazzeo, A.T., Gajavelli, S., Bullock, M.R., Mitochondrial neuroprotection in traumatic brain injury: rationale and therapeutic strategies. CNS Neurol. Disord. Drug Targets 13:4 (2014), 606–619.
141. Zhang, Y.B., Li, S.X., Chen, X.P., Yang, L., Zhang, Y.G., Liu, R., Tao, L.Y., Autophagy is activated and might protect neurons from degeneration after traumatic brain injury. Neurosci. Bull. 24 (2008), 143–149.
142. Zhang, Z., Zhang, Z.Y., Wu, Y., Schluesener, H.J., Immunolocalization of Toll-like receptors 2 and 4 as well as their endogenous ligand, heat shock protein 70, in rat traumatic brain injury. Neuroimmunomodulation 19 (2012), 10–19.
143. Zhao, G.W., Wang, Y., Li, Y.C., Jiang, Z.L., Sun, L., Xi, X., He, P., Wang, G.H., Xu, S.H., Ma, D.M., Ke, K.F., The neuroprotective effect of modified Shengyu decoction is mediated through an anti-inflammatory mechanism in the rat after traumatic brain injury. J. Ethnopharmacol. 151 (2014), 694–703.
144. Ziebell, J.M., Morganti-Kossmann, M.C., Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurother.: J. Am. Soc. Exp. Neuro Ther. 7 (2010), 22–30.
145. Zohar, O., Rubovitch, V., Milman, A., Schreiber, S., Pick, C.G., Behavioral consequences of minimal traumatic brain injury in mice. Acta Neurobiol. Exp. (Wars) 71:1 (2011), 36–45.